Table 1 Baseline characteristics of melanoma patients on phase Ib portion

Age

 Median

65

 Range

55–84

Sex

 Male

7 (54%)

 Female

6 (46%)

Race/Ethnicity

 White Non-Hispanic

11 (84.6%)

 White Hispanic or Latino

1 (7.7%)

 Black or African American

1 (7.7%)

ECOG Performance Status

 0

7 (54%)

 1

6 (46%)

BRAF status

 V600E/K mutated

4 (31%)

 WT

9 (69%)

LDH

 ≤ Upper limit of normal

7 (54%)

 > Upper limit of normal

6 (46%)

All lines of prior treatment

 Median

2

 Range

1–6

Lines of prior immunotherapy-based treatment only

 Median

2

 Range

1–4

Prior Ipi + Nivo

11 (85%)